Seres Therapeutics Inc (NAS:MCRB)
$ 0.915 0.038 (4.33%) Market Cap: 156.22 Mil Enterprise Value: 176.53 Mil PE Ratio: 0 PB Ratio: 6.54 GF Score: 47/100

Q1 2020 Seres Therapeutics Inc Earnings Call Transcript

May 07, 2020 / 12:30PM GMT
Release Date Price: $4.27 (+12.37%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Seres Therapeutics Q1 earnings conference call. (Operator Instructions) After the speaker presentation, there will be a question-and-answer session. (Operator Instructions) I must advise you that this conference is being recorded today, May 7, 2020.

I would now like to hand the conference over to your speaker for today, Dr. Carlo Tanzi of Investor Relations. Carlo, please go ahead.

Carlo Tanzi
Seres Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you and good morning. Our press release with the company's first quarter 2020 financial results and a business update became available at 7:00 a.m. Eastern Time this morning, and can be found on the Investors & Media section of the company's website.

I'd like to remind you that we will be making forward-looking statements relating to the timing, enrollment and results of our clinical studies, regulatory approval, the promise and potential impact of any of our microbiome therapeutics, the sufficiency of our cash

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot